Showing results (141-150 of 166) with videos related to
Sort By:
Pageof 17
Plos One|January 5, 2016
The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver CarcinogenesisYuhei Shibata, Takeshi Hara, Junji Nagano, et al.Internal Medicine (Tokyo, Japan)|October 1, 2023
Comparison of the Serial Humoral Immune Response according to the Immunosuppressive Treatment after SARS-CoV-2 mRNA VaccinationHiroya Menjo, Midori Hasegawa, Hidetsugu Fujigaki, et al.Plos One|September 17, 2013
Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammationJunji Nagano, Masahito Shimizu, Takeshi Hara, et al.Annals of Clinical Biochemistry|April 21, 2022
Validation of the Martin method to estimate low-density lipoprotein cholesterol concentrations in Japanese populations and a modified method for laboratory information system applicationHidekazu Ishida, Yasuko Yamamoto, Midori Saito, et al.Cancer Genomics & Proteomics|December 29, 2022
Cytomorphology and Gene Expression Signatures of Anchorage-independent Aggregations of Oral Cancer CellsKouhei Sakurai, Akira Nagai, Tatsuya Ando, et al.The Prostate|September 16, 2024
Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancerTaku Kato, Eiji Sugihara, Yuko Hata, et al.Frontiers in Toxicology|June 23, 2022
Accurate Evaluation of Hepatocyte Metabolisms on a Noble Oxygen-Permeable Material With Low Sorption CharacteristicsMasaki Nishikawa, Hiroyasu Ito, Fumiya Tokito, et al.Cancer Science|February 11, 2012
Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenaseKengo Ogawa, Takeshi Hara, Masahito Shimizu, et al.European Journal of Haematology|December 10, 2009
Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOPTakeshi Yoshikawa, Takeshi Hara, Hisashi Tsurumi, et al.The Journal of Pharmacy and Pharmacology|July 20, 2010
Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patientsAkio Suzuki, Yoshinori Imanishi, Shiho Nakano, et al.Pageof 17